Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer

Burt Cagir, Alyssa Gelmann, Jason Park, Tracy Fava, Alexander Tankelevitch, Edwin W. Bittner, Eric J. Weaver, Juan P. Palazzo, David Weinberg, Robert D. Fry, Scott A. Waldman

Research output: Contribution to journalArticle

88 Scopus citations

Abstract

Background: Patients with stage II colorectal cancer and no histologic evidence of lymph node invasion develop recurrent disease, presumably because of undetected micrometastases. Guanylyl cyclase C is expressed by intestinal and colorectal cancer cells but not by extraintestinal tissues or tumors. Objective: To examine the expression of guanylyl cyclase C messenger RNA (mRNA) in lymph nodes of patients with node-negative colorectal cancer who did and did not have recurrent disease. Design: Case-control study. Setting: Tertiary care academic medical center. Patients: Paraffin-embedded lymph nodes were obtained from 21 patients with histologically confirmed node- negative colorectal cancer who had undergone resection. Controls included 11 patients without disease recurrence 6 or more years after resection, and case-patients included 10 patients whose disease recurred up to 3 years after resection. Measurements: Sections of paraffin-embedded lymph nodes were obtained from each patient and were pooled, and their RNA was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR). Results: Guanylyl cyclase C mRNA was expressed in lymph nodes from all patients with recurrent disease but not in those from patients without recurrent disease (P = 0.004). Nested RT-PCR that used primers for carcinoembryonic antigen, a marker for colorectal cancer, identified carcinoembryonic antigen mRNA in lymph nodes from only 1 of 10 patients with recurrent disease and those from 0 of 11 patients without recurrent disease. The odds ratio for death associated with expression of guanylyl cyclase C mRNA in regional lymph nodes was 15.0 (95% CI, 1.1 to 756.7). Conclusions: Expression of guanylyl cyclase C mRNA in lymph nodes is associated with recurrence of colorectal cancer in patients with stage II disease. Analysis of guanylyl cyclase mRNA expression by RT-PCR may be useful for colorectal cancer staging.

Original languageEnglish (US)
Pages (from-to)805-812
Number of pages8
JournalAnnals of internal medicine
Volume131
Issue number11
DOIs
StatePublished - Dec 7 1999

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Cagir, B., Gelmann, A., Park, J., Fava, T., Tankelevitch, A., Bittner, E. W., Weaver, E. J., Palazzo, J. P., Weinberg, D., Fry, R. D., & Waldman, S. A. (1999). Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Annals of internal medicine, 131(11), 805-812. https://doi.org/10.7326/0003-4819-131-11-199912070-00002